NinePointTwo Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,437
Closed -$265K 329
2023
Q2
$265K Buy
+10,437
New +$253K 0.1% 96
2022
Q4
Sell
-19,111
Closed -$317K 262
2022
Q3
$317K Buy
+19,111
New +$430K 0.13% 88

Other funds holding VCYT

NinePointTwo Capital's VCYT Position: Q3 2023 in Review

NinePointTwo Capital sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 10,437 shares — an estimated $265K sold.

NinePointTwo Capital first reported a position in VCYT in Q3 2022 and held it in 2 quarters. The position peaked at $317K in Q3 2022. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.

  • NinePointTwo Capital reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
  • NinePointTwo Capital sold 10,437 Veracyte shares in Q3 2023, an estimated $265K.
  • NinePointTwo Capital first reported a position in Veracyte in Q3 2022 and held it in 2 quarters.
  • NinePointTwo Capital's Veracyte position peaked at $317K in Q3 2022.
  • 236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.

Based on NinePointTwo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.